ANNEXON INC. - COMMON STOCK

3.4400

07-February-25 15:45:00

15 minutes delayed

Stocks

-0.1300

-3.64%

Today's range

3.4250 - 3.6000

ISIN

N/A

Source

NASDAQ

Annexon Biosciences Reports Fourth Quarter and Full-Year 2020 Financial Results with Recent Business Highlights

25 Mar 2021 06:00:01 By Nasdaq GlobeNewswire
Annexon Advances Classical Complement Platform with Initiation of Global Phase 2 ARCHER Trial in Patients with Geographic Atrophy

01 Mar 2021 06:00:00 By Nasdaq GlobeNewswire
Annexon Welcomes William H. Carson, M.D. to the Board of Directors

08 Feb 2021 06:00:00 By Nasdaq GlobeNewswire
Annexon Highlights Recent Achievements and Outlines Expected Key Milestones in 2021 for Its Broad Portfolio of Complement Therapeutics

12 Jan 2021 06:00:00 By Nasdaq GlobeNewswire
Annexon to Present at the J.P. Morgan 39th Annual Healthcare Conference

05 Jan 2021 06:00:01 By Nasdaq GlobeNewswire

<<
<
2
3
4
5
6
>

I Agree NetDania's website uses cookies. By continuing browsing our website, you agree to our Cookie Policy, Privacy Policy and Terms and Conditons.